Skip to main content
Full access
Letters
Published Online: 1 July 2011

Psychosis Secondary to ALS in the Absence of Dementia: A Convincing Case

Publication: The Journal of Neuropsychiatry and Clinical Neurosciences
To the Editor: Psychiatric symptoms in amyotrophic lateral sclerosis (ALS) are thought to be restricted to cognitive and depressive symptoms.1 However, early reports considered psychosis as a possible component of the disease.2,3 Various cases have been reported, including a man requesting an amygdalectomy because of a somatic delusion.4,5
We report on the case of 68-year-old man with ALS who acutely developed a bizarre somatic delusion in the absence of dementia. The debate regarding the “organicity” of the psychosis lead to delayed treatment and increased morbidity.

Case Report

The patient had an 18-month history of bulbar ALS, was communicating in writing because of anarthria, and was being treated with riluozole. In a long-term care facility, he acutely developed the belief that a person called “chief” was located in his throat and prevented him from drinking properly. He also believed that this person was the “key to finding the cure for ALS.” He was admitted because of repeated self-mutilation to his throat area using suction tubes and scissors in an effort to remove the “chief.” He was initially investigated in the neurology department. Other than the delusion, there were no new neuropsychiatric symptoms, and his level of consciousness was unimpaired. There was no evidence of delirium. A cerebral CT scan and a recent brain MRI were normal. The laboratory work-up was normal. A recent behavioral neurology assessment revealed only mild comprehension deficits. Consequently, the patient was transferred to the psychiatric emergency department because the symptoms were deemed to be “primarily psychiatric.” The psychiatric assessment revealed longstanding narcissistic and Cluster A personality traits, but no history of psychotic or mood disorder. There was no medication likely to have induced psychosis. Given the acute onset of a bizarre delusion at a late age and in the absence of previous psychiatric history, the diagnosis was psychotic disorder due to ALS.
During the debate around which service should be admitting the patient, he developed an aspiration pneumonia. He was then admitted to neurology for concurrent IV antibiotic and haloperidol 1 mg po hs treatments and discharged to his nursing home 5 weeks later. An outpatient neuropsychiatric assessment was performed less than 2 weeks after discharge because of similar self-mutilations. The somatic delusion was still present. Because of insomnia and increased psychomotor retardation with haloperidol, the treatment was changed to olanzapine 5 mg po hs, and eventually increased to 10 mg. The self-harm risk was reduced by behavioral measures, but the patient died in the following weeks from his progressing ALS.

Discussion

The acute onset of bizarre psychotic symptoms in the absence of past psychiatric history is an indication that these symptoms were most likely secondary to the ALS. Also, the content resembles a previous report of throat-related somatic delusion.4 This case highlights the rare but real occurrence of psychosis in ALS. The acute onset, course of illness, and nature of the delusions are important factors in the diagnostic assessment. More importantly, treatment plans should be based on the needs of the patient as opposed to theoretical debates about the “organicity” of the psychosis.

References

1.
David A, Fleminger S, Kopelman M, et al.: Lishman's Organic Psychiatry: A Textbook of Neuropsychiatry, 4th Edition. New York, John Wiley & Sons-Blackwell Scientific, 2009
2.
Androp S: Amyotrophic lateral sclerosis with psychosis. Psychiatr Q 1940; 14:818–825
3.
Friedlander J, Kesert B: The role of psychosis in amyotrophic lateral sclerosis. J Nerv Ment Dis 1948; 107:243–250
4.
Friedlander J, Kesert B: Role of psychosis in amyotrophic lateral sclerosis: report of case. Arch Neurol Psychiatry 1946; 27:554–555
5.
Enns M, Barakat S, Brown J: Amyotrophic lateral sclerosis presenting with psychosis. Psychosomatics 1993; 34:453–455

Information & Authors

Information

Published In

Go to The Journal of Neuropsychiatry and Clinical Neurosciences
Go to The Journal of Neuropsychiatry and Clinical Neurosciences
The Journal of Neuropsychiatry and Clinical Neurosciences
Pages: E33
PubMed: 21948920

History

Published online: 1 July 2011
Published in print: Summer 2011

Authors

Details

Simon Ducharme, M.D.
McGill University, Department of Psychiatry, Montreal Neurological Institute, Montreal, QC, Canada
Theodore T. Kolivakis, M.D., CM FRCPC (Psych)
McGill University, Department of Psychiatry, Montreal Neurological Institute, Montreal, QC, Canada

Notes

Corresponding author: Theodore T. Kolivakis; e-mail: [email protected]

Metrics & Citations

Metrics

Citations

Export Citations

If you have the appropriate software installed, you can download article citation data to the citation manager of your choice. Simply select your manager software from the list below and click Download.

For more information or tips please see 'Downloading to a citation manager' in the Help menu.

Format
Citation style
Style
Copy to clipboard

View Options

View options

PDF/EPUB

View PDF/EPUB

Get Access

Login options

Already a subscriber? Access your subscription through your login credentials or your institution for full access to this article.

Personal login Institutional Login Open Athens login
Purchase Options

Purchase this article to access the full text.

PPV Articles - Journal of Neuropsychiatry and Clinical Neurosciences

PPV Articles - Journal of Neuropsychiatry and Clinical Neurosciences

Not a subscriber?

Subscribe Now / Learn More

PsychiatryOnline subscription options offer access to the DSM-5-TR® library, books, journals, CME, and patient resources. This all-in-one virtual library provides psychiatrists and mental health professionals with key resources for diagnosis, treatment, research, and professional development.

Need more help? PsychiatryOnline Customer Service may be reached by emailing [email protected] or by calling 800-368-5777 (in the U.S.) or 703-907-7322 (outside the U.S.).

Media

Figures

Other

Tables

Share

Share

Share article link

Share